fund
cancer
contribut
septemb
cancer
research
uk
londonbas
nonprofit
announc
plan
increas
fund
centr
drug
develop
formerli
known
drug
develop
offic
help
scienc
fund
catch
dip
econom
recess
year
ago
organ
state
would
increas
invest
drug
develop
million
million
spread
next
five
year
sweet
spot
firstinclass
firstinman
studi
say
nigel
blackburn
director
centr
drug
develop
take
scientif
risk
pharmaceut
industri
cant
although
fund
direct
toward
studi
cancer
blackburn
say
especi
interest
research
low
surviv
rate
cancer
affect
brain
esophagu
pancrea
lung
polici
antiag
wrinkl
us
feder
trade
commiss
ftc
crack
us
divis
cosmet
giant
advertis
antiag
product
use
languag
made
item
sound
like
drug
compani
market
product
divis
clinic
proven
boost
gene
activ
stimul
product
youth
protein
claim
base
vitro
test
case
consum
evalu
human
clinic
trial
necessari
product
intend
affect
structur
function
human
bodi
would
nice
cosmet
could
alter
gene
turn
back
time
could
nt
support
claim
jessica
rich
director
ftc
bureau
consum
protect
washington
dc
said
statement
final
order
approv
septemb
bar
claim
cosmet
product
affect
gene
activ
accord
ftc
claim
support
compet
reliabl
scientif
evid
tax
devic
ahead
midterm
elect
us
septemb
countri
hous
repres
pass
job
america
bill
includ
section
repeal
excis
tax
medic
devic
initi
institut
part
afford
care
act
medic
devic
compani
vehement
oppos
tax
sinc
introduct
hous
repres
vote
repeal
tax
two
previou
occas
wherea
senat
vote
tax
fundament
flaw
say
jc
scott
chief
lobbyist
advam
trade
associ
repres
medic
technolog
compani
base
washington
dc
hamper
innov
hurt
medic
devic
industri
public
payment
effort
promot
greater
transpar
health
care
us
center
medicar
medicaid
servic
cm
launch
open
payment
databas
septemb
databas
list
payment
made
doctor
drug
medic
devic
compani
databas
show
inform
august
decemb
plan
expand
coverag
beyond
timefram
howev
open
payment
identifi
financi
relationship
benefici
could
caus
conflict
interest
say
shantanu
agraw
deputi
administr
director
center
program
integr
within
cm
simpli
make
data
avail
public
effort
critic
complic
interfac
difficult
navig
industri
organ
doctor
also
express
concern
lack
contextu
inform
payment
databas
ema
transpar
accord
new
polici
approv
octob
european
medicin
agenc
ema
headquart
london
make
clinic
trial
data
submit
drug
receiv
approv
agenc
public
avail
new
polici
appli
medicin
new
market
author
applic
submit
eu
drug
regul
futur
ema
also
hope
publish
individu
patient
data
consid
variou
privaci
data
protect
law
eu
order
guido
rasi
execut
director
ema
state
polici
document
high
degre
transpar
take
regulatori
decis
make
one
step
closer
eu
citizen
promot
betterinform
use
medicin
enteroviru
outbreak
us
face
outbreak
octob
us
center
diseas
control
prevent
cdc
confirm
case
includ
seven
death
infect
caus
viru
although
nonpolio
enterovirus
fairli
common
caus
estim
million
infect
everi
year
us
preval
strain
year
improv
diagnosi
agenc
start
use
newli
develop
realtim
revers
transcriptas
pcr
test
identifi
suspect
strain
viru
faster
previou
method
cut
time
take
sever
week
day
ultim
faster
test
help
better
show
trend
outbreak
sinc
august
monitor
chang
occur
accord
cdc
press
releas
push
paus
octob
white
hous
offic
scienc
technolog
polici
announc
mandatori
moratorium
futur
fund
studi
influenza
sudden
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
involv
gainoffunct
manipul
render
virus
virul
also
encourag
scientist
ongo
work
kind
voluntarili
paus
work
franci
collin
director
us
nation
institut
health
nih
said
statement
studi
entail
biosafeti
biosecur
risk
need
better
understand
although
end
date
fund
paus
us
govern
plan
deliber
come
new
polici
next
year
dengu
count
incid
dengu
fever
india
time
greater
current
report
accord
new
studi
publish
onlin
octob
diseas
previous
report
afflict
peopl
year
india
thought
affect
nearli
million
annual
studi
revis
total
econom
cost
inflict
medic
treatment
associ
cost
ill
like
lost
time
place
least
india
space
program
messag
govern
consum
dengu
import
continu
expend
effort
elimin
worthwhil
said
lead
author
studi
donald
shepard
health
economist
brandei
univers
waltham
massachusett
research
less
difficil
encapsul
pill
contain
frozen
human
fecal
matter
remark
success
treat
patient
clostridium
difficil
infect
accord
find
studi
publish
onlin
octob
although
group
work
similar
pill
first
studi
show
efficaci
approach
studi
patient
recur
c
difficil
infect
took
pill
cours
two
day
intervent
cure
diarrhea
major
symptom
infect
pillbas
trial
pave
way
cheaper
altern
tradit
fecal
transplant
reli
expens
procedur
like
colonoscopi
say
elizabeth
hohmann
infecti
diseas
specialist
boston
massachusett
gener
hospit
senior
investig
studi
pill
make
treatment
c
difficil
much
avail
peopl
ebola
czar
much
specul
obama
administr
name
ron
klain
us
ebola
respons
coordin
octob
klain
previous
serv
presid
case
hold
aol
founder
steve
case
hold
compani
well
gener
counsel
revolut
llc
invest
compani
posit
klain
coordin
domest
effort
contain
diseas
also
work
intern
agenc
combat
spread
ebola
speak
ahead
appoint
presid
barack
obama
said
may
make
sens
us
one
person
initi
surg
activ
regular
process
make
sure
cross
dot
go
forward
klain
report
homeland
secur
advisor
lisa
monaco
well
us
nation
secur
advisor
susan
rice
plea
offer
document
file
octob
indic
us
feder
prosecutor
offer
plea
bargain
dongpyou
han
former
iowa
state
univers
isu
biologist
accus
scientif
fraud
han
charg
four
count
feloni
make
fals
statement
grant
document
submit
nih
enter
guilti
plea
count
summer
natur
medicin
went
press
deal
reach
han
lawyer
request
delay
trial
third
request
past
three
novemb
februari
han
resign
isu
octob
investig
found
falsifi
result
mix
human
blood
rabbit
blood
make
experiment
aid
vaccin
seem
groundbreak
initi
claim
gener
tremend
interest
research
fund
us
govern
discoveri
fraud
isu
repay
nearli
million
research
grant
million
pend
grant
univers
cancel
